基本情報
- 標準SMILES
N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O- InChIKey
LEVWYRKDKASIDU-IMJSIDKUSA-N- 分子式
- C6H12N2O4S2
- 平均分子量
- 240.3 g/mol
- 単同位体質量
- 240.02384886
概要
L-cystine is the L-enantiomer of the sulfur-containing amino acid cystine. It has a role as an EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor, a flour treatment agent, a mouse metabolite, a Saccharomyces cerevisiae metabolite and a human metabolite. It is a cystine, a non-proteinogenic L-alpha-amino acid and a L-cysteine derivative. It is a conjugate acid of a L-cystine anion. It is an enantiomer of a D-cystine. It is a tautomer of a L-cystine zwitterion.
名称と識別子
- 優先名称
- (-)-Cystine
- IUPAC
- (2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid
名称と別名
名称をさらに表示
データベース識別子
- CAS
56-89-3、923-32-0- PubChem CID
- 67678
- DTXSID
DTXSID2046418- ChEMBL
CHEMBL590540- ChEBI
CHEBI:16283- UNII
- 48TCX9A1VT
- EC Number
- 200-296-3
- Nikkaji
- J9.172C
物性
構造計算による物性
- XLogP
- -6.3
- 極性表面積
- 177 Ų
- 水素結合供与体数
- 4
- 水素結合受容体数
- 8
- 回転可能結合数
- 7
- 重原子数
- 14
- 形式電荷
- 0
- 複雑度
- 192
実験および物理化学的性質
Cosmetics
Cosmetic ingredients (Cystine) -> CIR (Cosmetic Ingredient Review)
Antistatic; Hair conditioning
Physical Description
Solid; [Merck Index] White powder; [Sigma-Aldrich MSDS]
Solid
Collision Cross Section
145 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine]
148.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
147.3 Ų [M+Na-2H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
149.4 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
150.08 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]
151.5 Ų [M+Na]+
安全と法規制
GHS分類
GHS Classification
This chemical does not meet GHS hazard criteria for 97.8% (182 of 186) of all reports.
Not Classified
Aggregated GHS information provided per 186 reports by companies from 5 notifications to the ECHA C&L Inventory.
危険有害性情報
Regulatory Information
Chemical: L-Cystine
Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)
Status: Active Update: 13-09-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/5911
L-cystine: Does not have an individual approval but may be used under an appropriate group standard
Cystine: Does not have an individual approval but may be used under an appropriate group standard
毒性情報
化学と産業
薬理情報
Pharmacodynamics
L-Cystine is a covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. Cystine is a chemical substance which naturally occurs as a deposit in the urine, and can form a calculus (hard mineral formation) when deposited in the kidney. The compound produced when two cysteine molecules linked by a disulfide (S-S) bond. Cystine is required for proper vitamin B6 utilization and is also helpful in the healing of burns and wounds, breaking down mucus deposits in illnesses such as bronchitis as well as cystic fibrosis. Cysteine also assists in the supply of insulin to the pancreas, which is needed for the assimilation of sugars and starches. It increases the level of glutathione in the lungs, liver, kidneys and bone marrow, and this may have an anti-aging effect on the body by reducing age-spots etc.
用途と製造
Uses
CIR ingredient: Cystine
A non-essential amino acid (a dimerization of two cysteine molecules); [Merck Index] Used as a flavoring agent, dough strengthener, and nutritional supplement for foods; [FDA]
Use (kg; approx.) in Germany (2009): >500
関連反応
関連ノート
読み込み中…